Science
Flexible and protected – EurekAlert
In the fight against the coronavirus, SARS-CoV-2 researchers from multiple research institutions in Germany have combined their resources to study the spike protein on the surface of the virus. With its spikes, the virus binds to human cells and infects them.…
At the start of a COVID-19 infection, the coronavirus SARS-CoV-2 docks onto human cells using the spike-like proteins on its surface. The spike protein is at the centre of vaccine development because it triggers an immune response in humans. A group of German scientists, including members of the European Molecular Biology Laboratory (EMBL) in Heidelberg, the Max Planck Institute of Biophysics, the Paul-Ehrlich-Institut, and Goethe University Frankfurt have focused on the surface structure of the…
-
Noosa News21 hours agoTake a look behind the scenes at Noosa Arts Theatre
-
Noosa News21 hours agoWelcome for Greens homeless plan
-
General22 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General19 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails